Research into Chronic myelogenous leukemia spans multiple therapeutic approaches and trial phases.

11 total trials for this combination

Showing top 10 of 11 trials

Trials

NCT ID	Title	Status	Phase
NCT00041990	Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)	COMPLETED	PHASE2
NCT01690520	Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes	COMPLETED	PHASE2
NCT00042003	Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)	COMPLETED	PHASE2
NCT00285259	Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)	COMPLETED	PHASE2
NCT00412360	Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)	COMPLETED	PHASE3
NCT04904588	HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide	ACTIVE_NOT_RECRUITING	PHASE2
NCT02743351	Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies	COMPLETED	PHASE1/PHASE2
NCT02208037	Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)	COMPLETED	PHASE2
NCT00333840	Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia	COMPLETED	PHASE3
NCT00109707	A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies	COMPLETED	PHASE1/PHASE2

Related Pages

All Chronic myelogenous leukemia trials All trials in Duarte, United States